Type 2 diabetes mellitus (T2DM) is a serious, chronic, and progressive disease
that is rapidly increasing in prevalence. The disease now affects >10% of adults ...
Int J Clin Pract. 2002 May;56(4):251-7. Efficacy and safety of pioglitazone in type
2 diabetes: a randomised, placebo-controlled study in patients receiving stable ...
Drugs. 2006;66(1):85-109. Pioglitazone: a review of its use in type 2 diabetes
mellitus. Waugh J(1), Keating GM, Plosker GL, Easthope S, Robinson DM.
Aug 4, 2015 ... Pioglitazone (Actos) is a drug prescribed for the treatment of type 2 diabetes.
Side effects, drug interactions, dosing, and pregnancy and ...
Actos (pioglitazone) is a Type 2 diabetes medication that regulates blood sugar
levels in the body. Learn about its uses, interactions and side effects.
Nov 25, 2014 ... A 4-month, randomized, prospective, open-label comparison trial of
hydroxychloroquine vs. pioglitazone in type 2 diabetic patients ...
Oct 18, 2006 ... Pioglitazone for type 2 diabetes mellitus. Diseases of the heart and blood vessels
account for approximately 70% of all mortality in people with ...
Aug 17, 2012 ... The U.S. Food and Drug Administration today approved the first generic version
of Actos (pioglitazone hydrochloride) tablets. Along with diet ...
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Pioglitazone for
type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2006, ...
In clinical trials in patients with type 2 diabetes mellitus, pioglitazone as
monotherapy, or in combination with metformin, repaglinide, insulin or a